3-methoxytyramine has been researched along with Cerebral Ischemia in 1 studies
3-methoxytyramine: RN given refers to parent cpd
3-methoxytyramine : A monomethoxybenzene that is dopamine in which the hydroxy group at position 3 is replaced by a methoxy group. It is a metabolite of the neurotransmitter dopamine and considered a potential biomarker of pheochromocytomas and paragangliomas.
Excerpt | Relevance | Reference |
---|---|---|
"During 30 minutes of global forebrain ischemia in rats, striatal intracellular levels of dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) increase at the same time extracellular levels, measured by microdialysis, decrease." | 3.69 | Ischemia increases tissue and decreases extracellular levels of acid dopamine metabolites in the rat striatum: further evidence for active transport of metabolites. ( Clemens, JA; Mincy, RE; Phebus, LA, 1995) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Phebus, LA | 1 |
Mincy, RE | 1 |
Clemens, JA | 1 |
1 other study available for 3-methoxytyramine and Cerebral Ischemia
Article | Year |
---|---|
Ischemia increases tissue and decreases extracellular levels of acid dopamine metabolites in the rat striatum: further evidence for active transport of metabolites.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biological Transport, Active; Brain Ischemia; Corpus Striat | 1995 |